Canaccord Positive on Safety Profile of Kite’s Axi-Cel
A First Glance at This Hedge Fund Firm’s Strategic Q2 Moves in Biotech Sector
How Has a Deal Between Kite and Gilead Likewise Sent Juno Shares Jumping?
Greenblatt’s Gotham Management Turns Bullish on These 3 Biotech Stocks
What’s Gilead Sciences Next M&A Move? Kite Pharma!
Valeant’s Strengths Are Laced with Challenges Valeant Pharmaceuticals Intl Inc (NYSE:VRX) delivered a sound second-quarter print yesterday before the bell- but the troubled …
Valeant’s Siliq Not Competitive Enough in Psoriasis Market Valeant Pharmaceuticals Intl Inc’s (NYSE:VRX) fighting chances in the drug arena to compete may have just …
BTIG analyst Dane Leone sees new reason to step away from the sidelines on Kite Pharma Inc (NASDAQ:KITE), upgrading his rating from a …
Kite Pharma Inc (NASDAQ:KITE) announced that the FDA has accepted for priority review the Biologics License Application (BLA) for axicabtagene ciloleucel. The submission follows …
Valeant Shows Signs of the Stabilization Valeant Pharmaceuticals Intl Inc (NYSE:VRX) investors are finally waking up from their nightmare, as the stock rockets 20% …
